Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$20.54 - $31.0 $17,869 - $26,970
-870 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$16.03 - $31.1 $2,131 - $4,136
133 Added 18.05%
870 $27,000
Q4 2018

Feb 13, 2019

BUY
$16.51 - $51.33 $1,320 - $4,106
80 Added 12.18%
737 $14,000
Q3 2018

Nov 13, 2018

BUY
$43.15 - $67.97 $7,637 - $12,030
177 Added 36.88%
657 $34,000
Q2 2018

Aug 13, 2018

BUY
$35.06 - $51.17 $10,377 - $15,146
296 Added 160.87%
480 $21,000
Q1 2018

May 14, 2018

BUY
$19.05 - $41.76 $3,505 - $7,683
184 New
184 $7,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.